| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8958515 | Archivos de la Sociedad Española de Oftalmología | 2018 | 5 Pages |
Abstract
Dabrafenib and trametinib can lead to severe uveitis. Treatment with corticosteroids and discontinuation of therapy with dabrafenib and trametinib led to an anatomical and functional improvement, and resolved the episode rapidly. Ophthalmologists must be aware of this toxicity, given the increasing use of those drugs.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
T. Rueda-Rueda, J.L. Sánchez-Vicente, A. Moruno-RodrÃguez, F.E. Molina-Socola, A.C. MartÃnez-Borrego, F. López-Herrero,